Oxford Coronavirus Vaccine Is Safe and Triggers Immune Response

<p>Good news on the vaccine front: In early stage trials, a vaccine candidate from Oxford University and AstraZeneca caused no serious side effects and produces an immune response of both antibodies and T-cells. The U.S. has also paid $1.2 billion dollars to secure at least 300 million doses when it’s available. Dave Lawler, world editor at Axios, joins us for the latest on the Oxford vaccine.</p><p> </p> Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>